Background
==========

Angiosarcomas, which account for only 1 to 2% of all soft tissue sarcomas, are rare malignant tumors of endothelial origin \[[@B1],[@B2]\]. These tumors are usually found in the scalp and facial skin of elderly individuals, with a male preponderance \[[@B3]\]. Primary angiosarcoma of the small intestine is extremely rare; moreover, due to the difficulty of prompt and accurate diagnosis, its prognosis is very poor \[[@B1],[@B4]\]. To the best of our knowledge, few cases of primary angiosarcoma of the small intestine have been reported in the English literature \[[@B5]\], especially primary angiosarcoma of the small intestine with metastasis to the liver in a young patient.

Here, we report a 33-year-old gentleman who presented with abdominal pain of 4 months duration, which worsened in the last 2 weeks prior to presentation.

Case presentation
=================

A 33-year-old gentleman admitted to our hospital on 5 August 2011 presented with a 4-month history of pain in the left lower quadrant of the abdomen, which had worsened in the last 2 weeks before presentation.

Four months ago, the patient began experiencing abdominal pain in the lower left quadrant without any apparent cause. The symptoms became increasingly aggravated during the last 2 weeks before presentation. The presenting symptoms included paroxysmal colic in the left lower quadrant of the abdomen, fever, nausea and vomiting. The patient also experienced fatigue and an 8 kg weight loss over the last 4 months. In a nearby local hospital, an abdominal plain film was obtained, which showed intestinal tympanites.

For further treatment, the patient came to our outpatient department and was admitted to the Department of Gastroenterology. A physical examination revealed a male patient with tenderness in the left lower abdominal region. There was no hepatomegaly or splenomegaly. Laboratory tests were performed, and the results were normal, including the levels of carcinoembryonic antigen and carbohydrate antigen 19--9. Computed tomography (CT) scans of the whole abdomen showed a significantly thickened intestinal wall located at the end of the jejunum and the proximal ileum, excessive ascites and a few enlarged lymph nodes in the abdomen (Figure [1](#F1){ref-type="fig"}). Contrast-enhanced CT scans showed different degrees of enhancement in the hepatic arterial phase (Figure [2](#F2){ref-type="fig"}).

![Computed tomography scans of the whole abdomen showed a significantly thickened intestinal wall (yellow arrows) located at the end of the jejunum and the proximal ileum, excessive ascites (white arrows), a few enlarged lymph nodes in the abdomen (red arrow) and the location of the primary angiosarcoma of the small intestine (black arrow).](1477-7819-11-242-1){#F1}

![**Enhanced computed tomography scan. (A)** A significantly thickened intestinal wall (yellow arrows) located in the end of the jejunum and the proximal ileum, excessive ascites (white arrows) and a few enlarged lymph nodes in the abdomen (red arrow). **(B)** Different degrees of enhancement were noted in the hepatic arterial phase (blue arrows).](1477-7819-11-242-2){#F2}

An urgent general surgical consultation was required because of sudden severe aggravation of the abdominal pain. Abdominocentesis was performed, which showed a dark red fluid. The patient presented with peritonitis. Therefore, an emergency laparoscopic surgery was performed, which was later converted to a laparotomy following partial enterectomy. The operative findings included intra-abdominal bleeding of 1500 ml and an oedematous small intestine. Additionally, the greater omentum was found adherent to the small intestinal mesentery in the left upper abdomen with inflammation and blood oozing from the small intestine. During surgical exploration, dozens of irregular nodules of various sizes were found scattered on the surface of the liver. In addition, a mass of approximately 5.0 × 6.0 cm in size was found in the small intestine approximately 70 cm distal to the ligament of Treitz and was accompanied by an endoleak. During the operation, the tumor and the local mesentery of the small intestine were resected. Eight lymph nodes were examined, and two were found to be metastatic. On microscopic examination, vascular invasion of tumor tissue could be observed. The blood vessels of the tumor were abundant with tumor cells around them, and the tumor cells were arranged in a slit-shaped pattern (Figure [3](#F3){ref-type="fig"}). The immunohistochemistry results showed that the tumor cells were positive for CD31 and vimentin (Figure [4](#F4){ref-type="fig"}) and negative for CD34, actin, S-100, CD117 and CK56. Moreover, the Ki-67 proliferation index was less than 10% positive. On the basis of these findings, adenocarcinoma, intestinal tuberculosis, neuroendocrine tumor, malignant melanoma, Crohn's disease, gastrointestinal stromal tumor (GIST) and lymphoma were excluded. Hence, the diagnosis of primary angiosarcoma of the small intestine with metastasis to the liver was confirmed.

![**Microscopic examination. (A)** Tumour tissue can be observed invading the vascular cavity (hematoxylin and eosin stain; ×100). **(B)** Tumor blood vessels were abundant, with the tumor cells surrounding them (hematoxylin and eosin stain; ×400). **(C)** The tumor cells were arranged in a slit-shaped pattern (hematoxylin and eosin stain; ×400).](1477-7819-11-242-3){#F3}

![**Immunohistochemistry results.** The tumor cells were positive for **(A)** CD31 (hematoxylin and eosin stain; ×400) and **(B)** vimentin (hematoxylin and eosin stain; ×200).](1477-7819-11-242-4){#F4}

After surgical resection, the patient was managed with adjuvant chemotherapy and palliative care. Approximately 400 to 500 ml hemorrhagic fluid was drained during the postoperative period through the abdominal drains. Moreover, the volume of hemorrhagic fluid increased to 600 ml on the 6th postoperative day. Therefore, a cytologic examination was performed, which showed malignant cells, confirming the diagnosis of malignant ascites. The patient received frequent blood transfusions due to a progressive drop in hemoglobin. In the early morning hours of the 27th postoperative day, the patient experienced a sudden disturbance of consciousness along with a progressive decrease in blood pressure. Due to the above-mentioned circumstances, further treatment was refused by the patient's relatives. The patient died on the morning of the 27th postoperative day.

Discussion
==========

Angiosarcoma, a malignant neoplasm derived from the endothelial cells of blood vessels or lymphatic vessels, is characterized by aggressively proliferating and widely distributed tumor cells \[[@B6]\].

In 1879, Langhans and colleagues reported the first angiosarcoma in the spleen \[[@B7]\]. Thereafter, only a few cases of primary angiosarcoma involving the small intestine have been reported. Gentry and colleagues reviewed 106 vascular tumors of the gastrointestinal tract at the Mayo Clinic between 1925 and 1944, among which 16 angiosarcomas were found; furthermore, only three involved the small intestine \[[@B8]\]. Karpeh and colleagues reviewed 69 adult patients admitted to the Memorial Sloan-Kettering Cancer Center between 1982 and 1990. In this study, 35 angiosarcomas were found, and only 10 involved the viscus or retroperitoneum \[[@B9]\]. Naka and colleagues reviewed 99 Japanese patients with angiosarcoma diagnosed between 1974 and 1990, and no small intestinal angiosarcomas were found \[[@B3]\]. Allison and colleagues reviewed the cases of angiosarcoma that were diagnosed from 1990 to 2002 at the University of Washington and the Cleveland Clinic Foundation, finding only eight cases of angiosarcoma involving the gastrointestinal tract \[[@B10]\] (Table [1](#T1){ref-type="table"}).

###### 

Previous data regarding angiosarcoma and small intestinal angiosarcoma in the study population

  **Reference**                      **Study population**                                                                                        **Number of patients with angiosarcoma**  **Number of patients with small intestinal angiosarcoma**
  ---------------------------------- ---------------------------------------------------------------------------------------------------------- ------------------------------------------ -----------------------------------------------------------
  Gentry *et al*. \[[@B8]\] 1949     106 patients with vascular tumors of the gastrointestinal tract between 1925 and 1944.                                         16                     3
  Karpeh *et al*. \[[@B9]\] 1991     69 adult patients admitted to the Memorial Sloan-Kettering Cancer Center between 1982 and 1990.                                35                     ≤10
  Naka *et al*. \[[@B3]\] 1995       99 Japanese patients with angiosarcoma between 1974 and 1990.                                                                  99                     0
  Allison *et al*. \[[@B10]\] 2004   19 previously reported cases of angiosarcoma involving the gastrointestinal tract between 1990 and 2002.                       19                     8

To gain a deeper understanding of primary angiosarcoma of the small intestine, we searched the PubMed database. The following search terms were used: ("hemangiosarcoma"\[MeSH Terms\] OR "hemangiosarcoma"\[All Fields\] OR "angiosarcoma"\[All Fields\]) AND ("intestine, small"\[MeSH Terms\] OR "small intestine"\[All Fields\] OR "small bowel"\[All Fields\]) AND (English\[Language\]). Only 54 eligible articles were retrieved. We excluded articles that described secondary cases and articles describing animal angiosarcoma involving the small intestine. Finally, only 27 articles remained \[[@B1],[@B5],[@B11]-[@B35]\] (Table [2](#T2){ref-type="table"}).

###### 

Cases of primary angiosarcoma involving the small intestine reported in the English literature

  **Authors**                                  **Sex/age (years)**   **Primary or secondary**   **Site**                     **Immunohistochemical staining**                                                                          **History of prior radiation or other predisposing factor**                          **Presentation**                                                                          **Treatment**                                                      **Follow-up**
  -------------------------------------------- --------------------- -------------------------- ---------------------------- --------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------ ----------------------------------------------------------------------------------------- ------------------------------------------------------------------ ---------------------------------------------------------
  Maeyashiki *et al*. \[[@B11]\]               M/72                  Indeterminate              Small bowel                  Positive for CD31, CD34 and factor VIII                                                                   None                                                                                 Anemia, melaena                                                                           Resection and daily blood transfusions                             Died on hospital day 103
  Siderits *et al*. \[[@B12]\]                 M/79                  Primary                    Small bowel                  Strongly positive for CD31                                                                                None                                                                                 Obstruction                                                                               Resection                                                          Unknown
  Taxy and Battifora \[[@B13]\]                M/64                  Primary                    Small bowel                  Positive for Factor VIII, collagen type IV and vimentin                                                   Not available                                                                        Gastrointestinal bleeding                                                                 Resection                                                          Died 1 year after the initial diagnosis
  Taxy and Battifora \[[@B13]\]                F/57                  Primary                    Small bowel                  Positive for Factor VIII, collagen type IV                                                                Not available                                                                        Not available                                                                             Resection                                                          Died shortly after surgery
  Chami *et al*. \[[@B14]\]                    M/59                  Primary                    Small bowel                  Weakly positive for factor VIII-related antigen, Ulex europaeus I antigen and cytokeratin                 None                                                                                 Gastrointestinal bleeding, bowel obstruction, anorexiaand weight loss                     Resection and transfusions                                         Died on the 11th day after surgery
  Ordonez *et al*. \[[@B15]\]                  M/80                  Primary                    Small bowel                  Positive immunoreaction for FVIII-RAG                                                                     None                                                                                 Anemia, undue tiredness and weakness                                                      Resection                                                          Died on the 20th postoperative day
  Hwang *et al*. \[[@B16]\]                    F/60                  Primary                    Small bowel                  Positive for Ulex europaeus agglutinin 1                                                                  History of radiotherapy                                                              Diffuse abdominal pain                                                                    Resection                                                          Died 2 months after discharge
  Mohammed *et al*. \[[@B5]\]                  F/25                  Primary                    Small bowel                  Not available                                                                                             None                                                                                 Intermittent abdominal pain, weight loss, abdominal distension, hematemesis and malaena   Resection                                                          Died on the 11th day after surgery
  Fraiman *et al*. \[[@B17]\]                  M/85                  Primary                    Small bowel                  Strong positivity for vimentin and CD31; focal positivity for factor VIII and CD34                        None                                                                                 Weight loss, anemia, weakness and abdominal pain                                          Resection and thalidomide                                          Not available
  Selk *et al*. \[[@B18]\]                     M/57                  Primary                    Small bowel                  Not available                                                                                             History of radiation therapy                                                         Progressive abdominal distention and shortness of breath                                  Resection                                                          Died 4 months after surgery
  Berry *et al*. \[[@B19]\]                    M/51                  Primary                    Small bowel                  Positive for Ulex europaeus and vimentin                                                                  History of 3-year irradiation                                                        Peritonitis                                                                               Resection, adriamycin and dacarbazine                              Died 5 months after initial presentation
  Watanabe *et al*. \[[@B20]\]                 M/64                  Primary                    Duodenum and upper jejunum   Positive for vimentin and anti-endothelin-1                                                               Not available                                                                        Persistent gastrointestinal bleeding                                                      Not available                                                      Died of pulmonary metastasis 1 year after the operation
  Al Ali *et al*. \[[@B1]\]                    M/87                  Indeterminate              Small bowel                  Positive for CD31                                                                                         None                                                                                 Lethargy, weakness and anemia                                                             Resection                                                          Died 6 weeks after the initial diagnosis
  Khalil *et al*. \[[@B21]\]                   M/68                  Primary                    Small bowel                  Strongly positive for CD31, CD34 and vimentin                                                             30 year history of heavy occupational exposure to radiation and polyvinyl chloride   Gastrointestinal bleeding and melaena                                                     Resection                                                          Died 6 months after initial presentation
  Suzuki *et al*. \[[@B22]\]                   F/61                  Primary                    Ileum                        Positive for factor VIII-related antigen and Ulex europaeus agglutinin 1                                  20 year history of radiotherapy                                                      Abdominal pain                                                                            Resection and intra-abdominal cisplatin                            Died 1 year after initial presentation
  Cilursu \[[@B23]\]                           F/74                  Indeterminate              Small bowel                  Not available                                                                                             Not available                                                                        Melaena                                                                                   Resection                                                          Not available
  Delvaux *et al*. \[[@B24]\]                  M/67                  Primary                    Small bowel                  Positive for CD 31, CD 34, factor VIII-related antigen and keratin                                        Not available                                                                        Weight loss, intermittent severe abdominal pain and melaena                               Resection                                                          Died 3 months after diagnosis
  Policarpio-Nicolas *et al*. \[[@B25]\]       F/51                  Primary                    Small bowel                  Positive for CD 31, CD 34 and factor VIII-related antigen                                                 History of irradiation                                                               Abdominal pain                                                                            Resection                                                          Died 10 months after laparotomy
  Hansen *et al*. \[[@B26]\]                   F/76                  Primary                    Small bowel                  Positive for factor VIII and vimentin                                                                     History of irradiation                                                               Watery diarrhea, vomiting, weight loss and abdominal pain                                 Resection                                                          Died 5 months after operation
  Aitola *et al*. \[[@B27]\]                   F/50                  Primary                    Small bowel                  Positive for CD 31, CD 34 and factor VIII-related antigen                                                 ≥10 year history of radiotherapy                                                     Intestinal obstruction                                                                    Resection followed by combination chemotherapy with doxorubicin    1 year and 9 months after diagnosis, she was alive
  Aitola *et al*. \[[@B27]\]                   F/78                  Primary                    Jejunum                      Positive for factor VIII-related antigen, CD31, CD34 and Ulex europaeus                                   ≥10 year history of radiotherapy                                                     Intestinal obstruction                                                                    Resection                                                          Died of sepsis 2 years after diagnosis
  Knop *et al*. \[[@B28]\]                     M/72                  Primary                    Small bowel                  Not available                                                                                             Not available                                                                        Gastrointestinal bleeding and anemia                                                      Resection                                                          Not available
  Ogawa *et al*. \[[@B29]\]                    M/36                  Primary                    Small bowel                  Positive for factor VIII-related antigen                                                                  Not available                                                                        Abdominal pain and nausea                                                                 Surgical treatment                                                 Not available
  de Mascarenhas-Saraiva *et al*. \[[@B30]\]   M/82                  Primary                    Ileum                        Not available                                                                                             Not available                                                                        Melaena and increasing shortness of breath                                                Surgical treatment and transfusions                                Not available
  Turan *et al*. \[[@B31]\]                    Not available         Indeterminate              Jejunum                      Not available                                                                                             Not available                                                                        Acute abdominal signs                                                                     Resection and chemotherapy                                         Not available
  Liu *et al*. \[[@B32]\]                      F/39                  Primary                    Terminal ileum               Positive for CD31 and CD34                                                                                None                                                                                 Increasing right iliac fossa pain, abdominal bloating and vomiting                        Resection and chemotherapy                                         Not available
  Kelemen *et al*. \[[@B33]\]                  M/76                  Primary                    Small bowel                  Positive for CD31                                                                                         None                                                                                 Abdominal pain and fatigue                                                                Resection                                                          Died of cardiac arrest on the 9th day after surgery
  Fohrding *et al*. \[[@B34]\]                 M/84                  Primary                    Small bowel                  Positive for CD31, cytokeratin and vimentin; slightly weaker for CD34; Focally positive for factor VIII   Not available                                                                        Gastrointestinal bleeding                                                                 Resection, adjuvant chemotherapy with paclitaxel and transfusion   Not available
  Grewal *et al*. \[[@B35]\]                   M/73                  Primary                    Small bowel                  Positive for CD31                                                                                         None                                                                                 Gastrointestinal bleeding, weakness and melaena                                           Resection                                                          Died within 4 months of the diagnosis
  M, male; F, female                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

Only one younger case, a 25-year-old woman, was reported as having primary angiosarcoma of the small intestine with normal liver, spleen, rectum, urinary bladder, kidneys, uterus and adnexae \[[@B5]\]. To our knowledge, there are few reports of primary angiosarcoma of the small intestine with metastasis to the liver among such young patients in the English literature.

Intestinal angiosarcoma often presents with gastrointestinal bleeding, abdominal pain, intestinal obstruction, abdominal distention, weight loss, shortness of breath, anemia and weakness \[[@B5],[@B10]\].

Young and colleagues reviewed angiosarcoma with a focus on clinical trials and outlined its risk factors \[[@B2]\]. According to these authors, the risk factors for angiosarcoma were varied and are listed in Figure [5](#F5){ref-type="fig"}.

![Risk factors for angiosarcoma.](1477-7819-11-242-5){#F5}

Magnetic resonance imaging (MRI), CT, positron emission tomography (PET), X-rays, ultrasound, endoscopy, immunohistochemical testing and a pathological examination can contribute to the diagnosis of angiosarcoma \[[@B2],[@B30],[@B31]\]. MRI, CT, abdominal X-rays and ultrasound are used to delineate the extent of the lesions in the preoperative period of abdominal angiosarcoma \[[@B2],[@B31]\]. CT and PET may be helpful for detecting metastases in the preoperative period \[[@B2]\]. The lesions and the sources of bleeding can be detected by endoscopy. Meanwhile, endoscopic biopsy can be performed; significantly, wireless capsule endoscopy is a new endoscopic method that can help to improve the diagnosis of deep small intestinal pathology \[[@B30]\]. Von Willebrand factor, CD34, CD31, Ulex europaeus agglutinin 1, vascular endothelial growth factor, melanocytic markers (such as S100), human melanoma black-45, melanoma antigen and cytokeratins all are useful for diagnosis and differential diagnosis \[[@B2]\]. Moreover, poorly differentiated adenocarcinoma, intestinal tuberculosis, neuroendocrine tumor, malignant melanoma, Crohn's disease, GIST, lymphoma and mesothelioma should be excluded, although with difficulty, in differential diagnosis \[[@B10],[@B33]\]. Pathological and immunohistochemical examinations can contribute to the definitive diagnosis of angiosarcoma \[[@B21]\].

Due to the rarity of randomized trials and prospective studies, the management guidelines for other soft tissue sarcomas tend to be utilized when dealing with angiosarcoma \[[@B2]\]. Complete surgical excision tends to be impossible due to the aggressive proliferation and wide metastasis of angiosarcoma \[[@B1]\]. In the current setting, surgical excision associated with adjuvant radiotherapy and/or chemotherapy may be useful; however, the efficacy of these treatments for angiosarcoma remains unclear. Therefore, further studies are desperately needed to determine the optimal treatment for angiosarcoma \[[@B1]\].

Generally speaking, the prognosis of angiosarcoma is very poor. Moreover, several investigators have noted that the site of angiosarcoma tends to affect prognosis \[[@B2]\], and the prognosis of angiosarcoma of the small intestine is significantly worse than that of angiosarcoma at any other site \[[@B17]\]. Indeed, most patients die within a few months of diagnosis, and some die within the postoperative period \[[@B17]\]. Patients with intestinal angiosarcomas who survive over 1 year after diagnosis are extraordinarily rare \[[@B14]\].

Conclusion
==========

Primary angiosarcoma of the small intestine is an extremely rare and aggressive soft-tissue malignant tumor. The findings of this case report are of extreme significance. To our knowledge, this may be the first report of primary angiosarcoma of the small intestine with metastasis to the liver in such a young patient. In the future, we should focus on similar cases to ensure early diagnosis and proper treatment.
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